Positron Emission Tomography and Computed Tomography Contributions to Patient Dose and Personnel Exposure to Radiation during PET/CT-Guided Tumor Ablations

J Vasc Interv Radiol. 2022 Oct;33(10):1234-1239. doi: 10.1016/j.jvir.2022.07.001. Epub 2022 Jul 8.

Abstract

This study sought to quantify the positron emission tomography (PET) and computed tomography (CT) components of patient radiation doses and personnel exposure to radiations during PET/CT-guided tumor ablations and assess the utility of a rolling lead shield for operator protection. Two operators performed 21 PET/CT-guided ablations behind a customized, 25-mm-thick lead shield with midchest-to-midthigh coverage. The mean patient radiation dose per procedure was 3.90 mSv ± 1.13 (11.3%) from PET and 30.51 mSv ± 19.05 (88.7%) from CT. The mean primary and secondary operator exposure outside neck-level thyroid shields was 0.05 and 0.02 mSv per procedure, respectively. The radiation exposure levels behind the rolling lead shield, inside the primary operator's thyroid shield, and on the other personnel were below the measurable threshold cumulatively over 21 procedures. The mean PET exposure level at continuous close proximity to patients was 0.02 mSv per procedure. The PET radiation doses to the patients and personnel were small. Thus, the rolling lead shield provided limited benefit.

MeSH terms

  • Humans
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / radiotherapy
  • Neoplasms* / surgery
  • Occupational Exposure* / adverse effects
  • Occupational Exposure* / prevention & control
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography
  • Radiation Dosage
  • Radiation Exposure* / adverse effects
  • Radiation Exposure* / prevention & control
  • Tomography, X-Ray Computed / adverse effects
  • Tomography, X-Ray Computed / methods